Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia

FEBS Lett. 2002 Jun 19;521(1-3):67-71. doi: 10.1016/s0014-5793(02)02824-7.

Abstract

The gene encoding a transmembrane glycoprotein LIG-1, of which the extracellular region was organized with the leucine-rich repeats and immunoglobulin-like domains, was disrupted in mice by gene targeting. LIG-1-deficient mice developed a skin change on the tail and facial area after birth. The affected skin was histologically reminiscent of the epidermis in human common skin disease 'psoriasis'. LIG-1 was expressed in basal cells of the epidermis and outer root sheath cells of hair follicles in mice. Interestingly, the LIG-1 expression was apparently down-regulated in the psoriatic lesions, suggesting that LIG-1 inversely correlates with proliferative ability of epidermal keratinocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / metabolism
  • Abnormalities, Multiple / pathology
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cell Differentiation
  • Cell Division
  • DNA, Complementary
  • Epidermis / metabolism
  • Epidermis / pathology
  • Gene Expression
  • Gene Targeting
  • Humans
  • Keratinocytes / cytology
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / physiology*
  • Mice
  • Mice, Knockout
  • Molecular Sequence Data
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Psoriasis / genetics
  • Psoriasis / metabolism*
  • Psoriasis / pathology
  • Skin Abnormalities / metabolism
  • Skin Abnormalities / pathology

Substances

  • DNA, Complementary
  • LRIG1 protein, human
  • Lrig1 protein, mouse
  • Membrane Glycoproteins
  • Nerve Tissue Proteins

Associated data

  • GENBANK/AB050468
  • GENBANK/D78572